BTK inhibitors synergise with 5-FU to treat drug-resistant TP53-null colon cancers. Lavitrano M, Ianzano L, Bonomo S, Cialdella A, et al. J Pathol 2020;250:134-147.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lavitrano M, Ianzano L, Bonomo S, Cialdella A, et al. BTK inhibitors synergise with 5-FU to treat drug-resistant TP53-null colon cancers. J Pathol 2020;250:134-147.
PMID: 31518438